‘Major, Major Game-Changer’: Ebola Spreads to Big Congo City

By Associated Press – Re-Blogged From Newsmax Health

Congo’s Ebola outbreak has spread to a crossroads city of more than 1 million people in a troubling turn that marks the first time the vast, impoverished country has encountered the lethal virus in an urban area.

“This is a major, major game-changer in the outbreak,” Dr. Peter Salama, the World Health Organization’s deputy director-general of emergency preparedness and response, warned on Thursday.

Continue reading

Advertisements

FDA OKs 1st Migraine Drug

By Associated Press – Re-Blogged From Newsmax Health

The FDA has approved the first drug designed to prevent chronic migraines. Aimovig is injected monthly just under the skin using a pen-like device and will cost $6,900 per year without insurance.

The Food and Drug Administration’s action clears the monthly shot for sale. Aimovig is the first in a new class of long-acting drugs for preventing migraines. Three other shots are expected to win approval by next year, and several pills for preventing migraines are being tested.

Continue reading

Engineered Antibodies Block HIV Infection in Primates for 6 Months

Immune Therapy Scores Big Win Against Lung Cancer in Study

By Associated Press – Re-Blogged From Newsmax

For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It’s the biggest win so far for immunotherapy, which has had much of its success until now in less common cancers.

In the study, Merck’s Keytruda, given with standard chemotherapy, cut in half the risk of dying or having the cancer worsen, compared to chemo alone after nearly one year. The results are expected to quickly set a new standard of care for about 70,000 patients each year in the United States whose lung cancer has already spread by the time it’s found.

Continue reading

Cancer Vaccine to Be Tested in Lymphoma Patients

By Nick Tate – Re-Blogged From Newsmax Health

Stanford Univesity researchers are recruiting lymphoma patients to test a new cancer vaccine that had a 97 percent success rate in “curing” mice with cancer.

The clinical trial will involve about 15 patients with low-grade lymphoma and begin by the end of the year, according to a Stanford news release.

 Lead research Dr. Ronald Levy, director of the lymphoma program at the Stanford Cancer Institute in California, said he believes the treatment could be useful for many tumor types.

Continue reading

Cancer “Vaccine” That Wipes out Tumors Ready for Human Trial

By Chelsea Gohd – Re-Blogged From Futurism

In Brief: After showing remarkable results in animal models, a new localized immunotherapy that targets the tumor with a simple injection is ready to enter clinical trials.

Cancer “Vaccine”

Researchers at Stanford University have developed a compound that when injected into a tumor destroys it along with all the other cancerous masses present in the body.

Continue reading

New 1918 Style Flu Pandemic Fear

By Eric Worrall – Re-Blogged From http://www.WattsUpWithThat.com

This isn’t a climate article, it is about a real problem.

Back in 1918, the infamous flu pandemic killed an estimated 3-5% of the population of the time – 50-100 million people. The awful potential of a new 1918 style flu Pandemic to sweep the world and kill millions, perhaps billions, despite all our medical advances, makes every flicker of infectious ability for novel strains of flu newsworthy.

H1N1 Flu Virus.

H1N1 Flu Virus. By NIAID (H1N1 Flu Virus) [CC BY 2.0], via Wikimedia Commons

Continue reading